Heartland Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Heartland Bank & Trust's BMY Position: Q2 2021 in Review
Heartland Bank & Trust sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 11,304 shares — an estimated $714K sold.
Heartland Bank & Trust first reported a position in BMY in Q4 2020 and held it in 2 quarters. The position peaked at $928K in Q4 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Heartland Bank & Trust reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Heartland Bank & Trust sold 11,304 Bristol-Myers Squibb shares in Q2 2021, an estimated $714K.
- Heartland Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 2 quarters.
- Heartland Bank & Trust's Bristol-Myers Squibb position peaked at $928K in Q4 2020.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Heartland Bank & Trust's 13F filing for Q2 2021, filed 30 Jul 2021.